Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Accumulated Expenses (2017 - 2026)

Inspire Medical Systems' Accumulated Expenses history spans 10 years, with the latest figure at $47.6 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 38.55% to $47.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $47.6 million, a 38.55% increase, with the full-year FY2025 number at $59.5 million, up 19.42% from a year prior.
  • Accumulated Expenses hit $47.6 million in Q1 2026 for Inspire Medical Systems, down from $59.5 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for INSP hit a ceiling of $59.5 million in Q4 2025 and a floor of $13.9 million in Q1 2022.
  • Historically, Accumulated Expenses has averaged $35.2 million across 5 years, with a median of $34.3 million in 2025.
  • The widest YoY moves for Accumulated Expenses: up 68.32% in 2023, down 3.37% in 2023.
  • Tracing INSP's Accumulated Expenses over 5 years: stood at $34.3 million in 2022, then increased by 14.35% to $39.3 million in 2023, then increased by 26.86% to $49.8 million in 2024, then increased by 19.42% to $59.5 million in 2025, then decreased by 20.04% to $47.6 million in 2026.
  • Business Quant data shows Accumulated Expenses for INSP at $47.6 million in Q1 2026, $59.5 million in Q4 2025, and $51.6 million in Q3 2025.